February is Oesophageal Cancer Awareness Month. Oesophageal cancer is one of the top five cancers worldwide — around 9,000 people are diagnosed in the UK each year. Our research focuses on developing non-invasive breath tests to detect cancer early by…
The Evening Standard highlighted our recent advancements in clinical screening for pancreatic cancer, showcasing the potential of our breath test to transform diagnostics. Read more →
A huge congratulations to Nayaab N A Kader and Henry D P Robb for finishing the London Marathon and raising money for Pancreatic Cancer UK. Nayaab also had the chance to discuss our breath test for early diagnosis of pancreatic…
Henry D P Robb and Nayaab N A Kader attended the Shoes of Hope event ahead of representing Pancreatic Cancer UK at the London Marathon. The event displays 797 pairs of shoes, representing the number of lives lost every month…
We held an event with our community partner Reviving Links to help set up an EDI advocacy group at Imperial College London, with productive discussions about barriers to recruitment in research and ways of creating a more inclusive research environment.
Professor George Hanna and team hosted the NIHR HealthTech Research Centre in In Vitro Diagnostics (HRC IVD) launch event, presenting the centre's exciting research that will support the development and adoption of diagnostics in healthcare.
The PANACEA team was invited to present at the 'Innovation in the early diagnosis of cancer' event at the BMA House, London, hosted by NHS Cancer Programme.
Mohamed Abulazayem has sampled the first participant of the HOPE study at Hammersmith Hospital and Meadows Centre for Health — a key milestone for the trial.
The VAPOR team joined Pancreatic Cancer UK at the Association of Medical Research Charities showcasing event at the House of Commons, discussing the urgent need for earlier detection in pancreatic cancer with ministers and MPs, and demonstrating our breath test…
